T-Cell Receptor Ligands: Every which Way They Can.
Simon J Davis, Caitlin O'Brien-Ball
Author Information
- Simon J Davis: Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Medical Research Council Human Immunology Unit, University of Oxford, Oxford, United Kingdom. Electronic address: simon.davis@imm.ox.ac.uk.
- Caitlin O'Brien-Ball: Medical Research Council Human Immunology Unit, University of Oxford, Oxford, United Kingdom.
No abstract text available.
- J Immunol. 2016 Nov 1;197(9):3429-3430
[PMID: 27824588]
- Front Immunol. 2018 Oct 08;9:2306
[PMID: 30349540]
- Trends Biochem Sci. 2018 Feb;43(2):108-123
[PMID: 29269020]
- J Immunol. 1989 Apr 15;142(8):2736-42
[PMID: 2467936]
- Nat Immunol. 2006 Aug;7(8):803-9
[PMID: 16855606]
- J Biol Chem. 2009 Nov 6;284(45):31028-37
[PMID: 19755427]
- Nat Immunol. 2018 May;19(5):487-496
[PMID: 29662172]
- Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17662-7
[PMID: 17971442]
- Immunol Rev. 2012 Nov;250(1):258-76
[PMID: 23046135]
- Biophys J. 2020 Jun 16;118(12):2879-2893
[PMID: 32407684]
- MC_UU_12010/4/Medical Research Council
- MC_UU-12010/4/Medical Research Council
- MC_UU_00008/4/Medical Research Council
- 207547/Z/17/Z/Wellcome Trust
- /Wellcome Trust
Ligands
Receptors, Antigen, T-Cell
T-Lymphocytes
Ligands
Receptors, Antigen, T-Cell
